2,4,5-Trihydroxymethamphetamine (THMA or THM) is a neurotoxin and a metabolite of MDMA. It has structural similarity to the dopamine neurotoxin 6-hydroxydopamine, and produces lasting serotonin deficits when administered centrally.[1][2]
See also
- 2,4,5-Trihydroxyamphetamine (THA)
- 3,4-Dihydroxyamphetamine (HHA; α-methyldopamine)
- 3,4-Dihydroxymethamphetamine (HHMA; α-methylepinine)
- 4-Hydroxy-3-methoxyamphetamine (HMA)
- 4-Hydroxy-3-methoxymethamphetamine (HMMA)
References
- ^ Ikram Elayan; James W. Gibb; Glen R. Hanson; Rodger L. Foltza; Heng Keang Lima; Michel Johnson (1992). "Long-term alteration in the central monoaminergic systems of the rat by 2,4,5-trihydroxyamphetamine but not by 2-hydroxy-4,5-methylenedioxymethamphetamine or2-hydroxy-4,5-methylenedioxyamphetamine". European Journal of Pharmacology. 221 (2–3): 281–288. doi:10.1016/0014-2999(92)90714-F. PMID 1358654.
- ^ Anne Neudörffer; Melanie Mueller; Claire-Marie Martinez; Annis Mechan; Una McCann; George A. Ricaurte; Martine Largeron (2011). "Synthesis and Neurotoxicity Profile of 2,4,5-Trihydroxymethamphetamine and its 6-(N-Acetylcystein-S-yl) Conjugate". Chem Res Toxicol. 24 (6): 968–978. doi:10.1021/tx2001459. PMC 3124246. PMID 21557581.
You must be logged in to post a comment.